Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Fechter

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
European Radiology|April 25, 2024
Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensationMontserrat Carles, Dejan Kuhn, Tobias Fechter, et al.
Frontiers in Oncology|December 3, 2019
Dosimetric Impact of Interfractional Variations for Post-prostatectomy Radiotherapy to the Prostatic Fossa-Relevance for the Frequency of Position Verification Imaging and Treatment AdaptationMona Splinter, Tilman Bostel, Ilias Sachpazidis, et al.
European Urology|August 12, 2025
Advancing Radioproteomics: Integration of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging with Localized Proteomic Profiling in Prostate CancerMatthias Fahrner, Constantinos Zamboglou, Simon K B Spohn, et al.
Frontiers in Oncology|November 2, 2020
Dosimetric Impact of the Positional Imaging Frequency for Hypofractionated Prostate Radiotherapy - A Voxel-by-Voxel AnalysisMona Splinter, Ilias Sachpazidis, Tilman Bostel, et al.
Frontiers in Oncology|October 16, 2019
Dosimetric Impact of Interfractional Variations in Prostate Cancer Radiotherapy-Implications for Imaging Frequency and Treatment AdaptationTilman Bostel, Ilias Sachpazidis, Mona Splinter, et al.
Radiation Oncology (London, England)|July 24, 2013
3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability studyHans Christian Rischke, Ursula Nestle, Tobias Fechter, et al.
Theranostics|July 23, 2016
(68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise ComparisonConstantinos Zamboglou, Florian Schiller, Tobias Fechter, et al.
Radiation Oncology (London, England)|March 22, 2026
Prediction of local failure after stereotactic radiotherapy in melanoma brain metastases using ensemble learning on clinical, dosimetric, and radiomic dataNanna E Wielenberg, Ilias Sachpazidis, Oliver Blanck, et al.
EJNMMI Physics|April 7, 2025
Open-source phantom with dedicated in-house software for image quality assurance in hybrid PET systemsCarmen Salvador-Ribés, Carina Soler-Pons, María Jesús Sánchez-García, et al.
Theranostics|August 2, 2021
Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studiesSimon K B Spohn, Alisa S Bettermann, Fabian Bamberg, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
European Radiology|April 25, 2024
Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensationMontserrat Carles, Dejan Kuhn, Tobias Fechter, et al.
Frontiers in Oncology|December 3, 2019
Dosimetric Impact of Interfractional Variations for Post-prostatectomy Radiotherapy to the Prostatic Fossa-Relevance for the Frequency of Position Verification Imaging and Treatment AdaptationMona Splinter, Tilman Bostel, Ilias Sachpazidis, et al.
European Urology|August 12, 2025
Advancing Radioproteomics: Integration of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging with Localized Proteomic Profiling in Prostate CancerMatthias Fahrner, Constantinos Zamboglou, Simon K B Spohn, et al.
Frontiers in Oncology|November 2, 2020
Dosimetric Impact of the Positional Imaging Frequency for Hypofractionated Prostate Radiotherapy - A Voxel-by-Voxel AnalysisMona Splinter, Ilias Sachpazidis, Tilman Bostel, et al.
Frontiers in Oncology|October 16, 2019
Dosimetric Impact of Interfractional Variations in Prostate Cancer Radiotherapy-Implications for Imaging Frequency and Treatment AdaptationTilman Bostel, Ilias Sachpazidis, Mona Splinter, et al.
Radiation Oncology (London, England)|July 24, 2013
3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability studyHans Christian Rischke, Ursula Nestle, Tobias Fechter, et al.
Theranostics|July 23, 2016
(68)Ga-HBED-CC-PSMA PET/CT Versus Histopathology in Primary Localized Prostate Cancer: A Voxel-Wise ComparisonConstantinos Zamboglou, Florian Schiller, Tobias Fechter, et al.
Radiation Oncology (London, England)|March 22, 2026
Prediction of local failure after stereotactic radiotherapy in melanoma brain metastases using ensemble learning on clinical, dosimetric, and radiomic dataNanna E Wielenberg, Ilias Sachpazidis, Oliver Blanck, et al.
EJNMMI Physics|April 7, 2025
Open-source phantom with dedicated in-house software for image quality assurance in hybrid PET systemsCarmen Salvador-Ribés, Carina Soler-Pons, María Jesús Sánchez-García, et al.
Theranostics|August 2, 2021
Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studiesSimon K B Spohn, Alisa S Bettermann, Fabian Bamberg, et al.
Pageof 4